Parocetan (parocetan) 20 mg Film-Coated Tablet
Prescription-only oral medicine containing the active substance parocetan
Quick Facts About Parocetan
Key Takeaways About Parocetan
- Prescription-only tablet: Parocetan 20 mg film-coated tablets are dispensed only on a valid prescription issued by a qualified healthcare professional, who will explain the indication, dose, and expected duration of treatment.
- Take exactly as prescribed: The approved dose, frequency, and treatment length depend on the clinical indication and the patient. Do not adjust the dose or stop treatment without first speaking to the prescriber or pharmacist.
- Always read the leaflet: The patient information leaflet packaged with each box of Parocetan contains the full, product-specific list of indications, contraindications, interactions, side effects, and storage conditions.
- Disclose everything at prescribing: Tell your doctor about all medical conditions, allergies, pregnancy status, and every medicine, supplement, or herbal product you are using before Parocetan is started.
- Report adverse effects: Any new, persistent, or severe symptom after starting Parocetan should be reported promptly to a pharmacist or doctor and, where available, to the national pharmacovigilance scheme.
What Is Parocetan and What Is It Used For?
Parocetan is a prescription-only film-coated tablet containing 20 mg of the active substance parocetan. It is supplied for oral use and is prescribed by qualified healthcare professionals for the specific indications authorised in the product's Summary of Product Characteristics (SmPC). The patient information leaflet included in each pack lists the exact conditions for which Parocetan has been licensed in your country.
Parocetan belongs to the category of prescription-only medicines (POM, or Rx), meaning that it is not available for self-selection from pharmacy shelves and cannot be legally supplied without a valid prescription from a doctor, dentist, or other authorised prescriber. Prescription-only status is assigned to medicines whose safe use depends on individual assessment, diagnosis, and monitoring that only a trained clinician can provide. It also ensures that potential interactions with other medicines and pre-existing conditions are considered before the first dose is taken.
The approved uses of Parocetan are described in the patient information leaflet (PIL) that is supplied inside the outer carton of every pack. The leaflet is a legally required, regulator-approved document that reflects the full therapeutic indication granted by the national or regional medicines agency (such as the European Medicines Agency in Europe, the Food and Drug Administration in the United States, or equivalent authorities elsewhere). It tells the patient exactly what the medicine is for, how to take it, and what to watch out for during treatment.
Because Parocetan is provided as a film-coated tablet, it is designed to be swallowed whole. The film coating protects the active ingredient from light, moisture, and the acidity of the stomach where applicable, can mask taste, and helps ensure that the active substance is released at the right site in the gastrointestinal tract. Film coating also makes the tablet easier to swallow than uncoated tablets and reduces friability during packaging and transport. Unless the prescriber or pharmacist explicitly states otherwise, film-coated tablets should not be crushed, split, or chewed.
A 20 mg strength tablet is a conventional adult dose unit that allows consistent, reproducible dosing. For patients who require higher total daily doses, the prescriber may instruct taking more than one 20 mg tablet at the same time; for patients who require lower doses, a smaller strength or an alternative dosing schedule may be prescribed. Any such adjustments must be made in consultation with the prescriber and never independently by the patient.
Parocetan, like every authorised prescription medicine, has gone through the regulatory pathway of preclinical testing, clinical trials, and marketing authorisation review. After launch, its safety is monitored continuously through pharmacovigilance systems that collect reports of suspected adverse drug reactions from healthcare professionals and patients. This ongoing surveillance can lead to updates in the patient information leaflet as the evidence base evolves, so it is always worth re-reading the leaflet when a new pack is dispensed.
This iMedic guide provides educational background on the safe use of Parocetan as a prescription medicine. It is not a substitute for the patient information leaflet supplied with your pack, and it does not replace the advice of your prescriber or pharmacist. If anything in your leaflet, on your prescription label, or in discussions with your healthcare provider differs from general advice given here, follow the product-specific guidance.
What Should You Know Before Taking Parocetan?
Before the first dose of Parocetan, tell your prescriber about all medical conditions, allergies, current medications (including over-the-counter products and herbal supplements), pregnancy or breastfeeding status, and plans to drive or operate machinery. Do not take Parocetan if you are allergic to parocetan or to any of the excipients listed in the patient information leaflet.
Every prescription for Parocetan should be preceded by a structured medication review. This review allows the prescriber to check that the indication is appropriate, that the dose is correct for the individual, that no contraindications or clinically significant interactions are present, and that monitoring requirements (for example, blood tests or symptom review) are understood. A well-prepared patient who brings a full list of current medicines, previous adverse reactions, and relevant medical history to the consultation significantly improves the safety of the prescribing process.
Contraindications
A contraindication is a condition or factor that makes the use of a medicine unsafe and therefore prohibits it. The most consistent contraindication that applies to any prescription tablet is a previous hypersensitivity reaction to the active ingredient or any excipient. You should not take Parocetan if:
- You have ever had an allergic reaction to parocetan or to any of the other ingredients listed in the patient information leaflet.
- You have been told in the past that you should not take this specific medicine by a healthcare professional.
- You have a medical condition listed in the "do not take" section of the patient information leaflet.
Because contraindications are product-specific, it is essential to review the leaflet supplied with your pack for the complete list relevant to Parocetan in your market. Any historical allergic reaction – particularly one involving rash, swelling of the face, lips, tongue, or throat, or difficulty breathing – should be mentioned at the time the prescription is issued so that the prescriber can make an informed choice.
Stop taking Parocetan and seek urgent medical attention if you develop symptoms of a serious allergic reaction. Warning signs include a widespread skin rash, hives, blistering or peeling skin, swelling of the face, lips, tongue, or throat, wheezing, difficulty breathing, feeling faint, or collapse. These can progress rapidly and are a medical emergency. Call your local emergency number immediately and bring the medicine pack with you so that the reaction can be clearly attributed to the correct product.
Warnings and Precautions
Beyond the absolute contraindications, several general precautions apply to the safe use of any prescription oral tablet. Inform your doctor or pharmacist before starting Parocetan if any of the following apply to you:
- You have a chronic medical condition such as hypertension, diabetes, heart disease, liver disease, or kidney disease.
- You have a history of gastrointestinal problems, including peptic ulcer or bleeding, if relevant to your medicine.
- You have a history of mental-health conditions, neurological disorders, or seizures.
- You are elderly (over 65), as dose adjustment is often needed because of age-related changes in drug metabolism and excretion.
- You have a low body weight, frailty, or malnutrition.
- You have any planned surgery or dental procedure during treatment.
- You have difficulty swallowing tablets or a known feeding-tube administration requirement.
Parocetan may, like other prescription medicines, cause side effects that can affect your ability to concentrate, react quickly, or perform tasks safely. If you experience drowsiness, dizziness, blurred vision, or confusion after taking a dose, do not drive, cycle, or operate machinery until you know how the medicine affects you personally. Alcohol may intensify some of these effects and should be avoided or limited unless your prescriber advises otherwise.
Keep the label on the box, the outer carton, and the patient information leaflet together until the pack is fully used, so that you can refer back to any instruction when questions arise. If the tablet looks visibly different from previous packs, discuss this with your pharmacist before taking it; on rare occasions, a generic substitution or a reformulation may change the appearance while keeping the active ingredient identical.
Pregnancy, Breastfeeding, and Fertility
Pregnant women, women planning pregnancy, and breastfeeding mothers should always discuss the use of Parocetan with their doctor or specialist. Prescription medicines can affect the developing foetus or pass into breast milk, and the decision to continue, start, or switch treatment must be made on an individual basis after careful weighing of benefits and risks. Never start or stop Parocetan during pregnancy or breastfeeding without medical advice, as abrupt changes can sometimes cause their own complications for both mother and baby.
If an unplanned pregnancy occurs during treatment with Parocetan, contact your prescriber as soon as possible. In most cases, treatment can be safely continued or adjusted under supervision. Where additional monitoring is required during pregnancy, your obstetric team, prescriber, and pharmacist will coordinate care to minimise risk.
Men and women of reproductive age who have concerns about the effect of any prescription medicine on fertility should raise this openly with their healthcare provider. Decisions around starting a family, assisted reproduction, or contraception during treatment are best made after a structured conversation covering the current evidence for Parocetan in the patient information leaflet and SmPC.
Always mention any prescription medicines you are taking – including Parocetan – during pre-operative or pre-procedural assessments. Some tablets need to be temporarily stopped, adjusted, or timed differently around anaesthesia or a procedure. Your surgeon, anaesthetist, or dentist needs a full medication list to plan safe care.
How Does Parocetan Interact with Other Drugs?
Parocetan may interact with other prescription and over-the-counter medicines. Always give your prescriber and pharmacist a complete, up-to-date list of everything you take, including vitamins, supplements, and herbal products, so that potential drug-drug interactions can be identified before they cause harm.
Drug interactions occur when one medicine changes the way another is absorbed, metabolised, distributed, or eliminated, or when two medicines have overlapping pharmacological effects. The result can be a loss of effectiveness of either drug, an amplified side-effect profile, or a new adverse reaction that would not be expected from either medicine alone. Interactions are one of the most common preventable causes of harm from prescription medicines, particularly in older adults and in patients taking several drugs at once (polypharmacy).
The patient information leaflet supplied with Parocetan lists the specific drug classes and individual medicines that have been identified as clinically significant. This is the definitive source for your particular product. However, the following general categories of medicines are frequently implicated in interactions across a wide range of prescription tablets and should always trigger a careful review by the pharmacist or prescriber:
Common Interaction Categories to Disclose
| Category | Examples | Why It Matters |
|---|---|---|
| Anticoagulants and antiplatelet agents | Warfarin, apixaban, rivaroxaban, dabigatran, edoxaban, clopidogrel, ticagrelor, low-dose aspirin | Potential changes in bleeding risk; dose or monitoring adjustments may be required |
| Medicines metabolised via CYP enzymes | Many statins, antidepressants, antiepileptics, benzodiazepines | Possible alteration of plasma drug levels through CYP450 enzyme interactions |
| Antibiotics and antifungals | Macrolides (e.g., erythromycin, clarithromycin), azole antifungals (fluconazole, itraconazole), rifampicin | Strong inhibitors or inducers of drug-metabolising enzymes; can raise or lower drug exposure |
| Cardiovascular medicines | ACE inhibitors, angiotensin receptor blockers, beta-blockers, diuretics, digoxin | Potential effects on blood pressure, renal perfusion, or cardiac conduction |
| Central nervous system drugs | Opioids, sedatives, hypnotics, antipsychotics, some antidepressants | Additive sedation, cognitive slowing, or respiratory depression |
| Herbal products and supplements | St John's wort, grapefruit juice, high-dose vitamins, over-the-counter remedies | Can unpredictably alter drug levels; often overlooked in medication reviews |
| Immunosuppressants and cytotoxics | Ciclosporin, tacrolimus, methotrexate | Narrow therapeutic range; even small changes in exposure can cause toxicity |
Lifestyle Factors That Affect Prescription Medicines
In addition to prescription drugs and supplements, several lifestyle factors can alter the effectiveness and safety of oral tablets such as Parocetan. These include:
| Factor | Possible Effect | Practical Advice |
|---|---|---|
| Alcohol | Can enhance sedative or gastrointestinal effects of some prescription tablets | Ask whether alcohol should be avoided or limited during treatment |
| Grapefruit and grapefruit juice | Inhibits CYP3A4, raising blood levels of several medicines | Ask your pharmacist whether grapefruit should be avoided while taking Parocetan |
| Smoking | Induces certain metabolic enzymes, lowering plasma levels of some drugs | If you stop or start smoking during treatment, notify your prescriber |
| Caffeine | May intensify side effects such as insomnia, palpitations, or restlessness | Moderate coffee, tea, and energy-drink intake, particularly at the start of treatment |
| Dehydration, fever, heat, diarrhoea, vomiting | Can alter kidney perfusion and drug excretion | Contact your prescriber if you become severely unwell with any of these |
| Vaccinations and travel medicine | Some interactions exist with live vaccines or antimalarial prophylaxis | Inform the travel clinic or vaccination service that you take Parocetan |
A useful practice is to keep a single, up-to-date medication list on your phone or on a printed card, listing every product you take, the strength, the dose, and the reason. Bring this list to every medical appointment, every pharmacy visit, and any hospital admission. This simple document dramatically reduces the risk of overlooked interactions.
What Is the Correct Dosage of Parocetan?
The correct dose of Parocetan is the one written on your prescription label and described in the patient information leaflet. Parocetan is supplied as a 20 mg film-coated tablet for oral use. Do not exceed the prescribed dose, do not take doses closer together than instructed, and do not stop treatment earlier than advised without first speaking to your prescriber.
Prescribers individualise the dose of Parocetan on the basis of the clinical indication, the patient's age, body weight, liver and kidney function, and any co-existing conditions or medications. The 20 mg strength tablet provides a convenient and reproducible unit for dose titration. If you require a higher total daily dose, the prescriber may instruct you to take two or more 20 mg tablets together or at different times of day; if you require a lower daily dose, an alternative schedule or a different strength may be prescribed.
Adults
General Principles for Adult Dosing
- Strength per tablet: 20 mg of parocetan (film-coated).
- Route: Oral – swallow whole with a glass of water.
- Timing: Take at the same time(s) each day as instructed, with or without food as specified in the leaflet.
- Duration: Continue for the full course prescribed, even if you feel better before finishing.
- Adherence: Use a pill organiser, phone reminder, or calendar to minimise missed doses.
- Review: Expect periodic follow-up appointments or pharmacy checks during long-term treatment.
Special Populations
| Population | General Considerations | Action |
|---|---|---|
| Elderly (over 65 years) | Slower clearance of medicines; higher sensitivity to side effects; often concurrent medications | Start low and go slow under supervision; regular medication review recommended |
| Hepatic impairment | Reduced metabolism of many prescription tablets | Prescriber may lower dose or choose alternative therapy; monitor liver function as indicated |
| Renal impairment | Reduced excretion; risk of drug accumulation | Dose adjustment based on estimated glomerular filtration rate (eGFR); periodic blood tests |
| Children and adolescents | Paediatric use only if authorised in the patient information leaflet | Paediatric dosing should be determined by a paediatrician familiar with the product |
| Pregnancy and breastfeeding | Individual benefit-risk assessment required | Discuss with obstetric team; do not start, stop, or change dose without medical advice |
| Low body weight or frailty | Altered pharmacokinetics and increased side-effect risk | Gentle titration; close review during the first weeks of treatment |
Children and Adolescents
Parocetan should only be used in children or adolescents if the patient information leaflet explicitly authorises paediatric use and a paediatrician has issued the prescription. Many prescription-only tablets licensed for adults are not suitable for children because of differences in pharmacokinetics, safety profile, or the absence of age-appropriate dosing studies. Never share a Parocetan tablet prescribed for an adult with a child, and never give any prescription medicine to a child without explicit medical advice.
What to Do if You Miss a Dose
If you forget a dose of Parocetan, take it as soon as you remember, unless it is nearly time for your next scheduled dose. In that case, skip the missed dose entirely and continue with your regular schedule. Do not take a double dose to make up for a missed tablet, because this can increase the risk of side effects. If you frequently forget doses, ask your pharmacist about practical strategies such as a weekly pill organiser, smartphone reminders, or linking doses to a daily habit like brushing your teeth.
What to Do if You Take Too Much
If you, a child, or another person has accidentally or intentionally taken more Parocetan than prescribed, seek medical advice immediately, even if you feel well. Call your local emergency number, poison-information hotline, or go to the nearest emergency department. Bring the medicine pack and the patient information leaflet with you so that the healthcare team can quickly identify the ingredient, strength, and quantity taken. The sooner an overdose is assessed, the better the outcome; most treatments for overdose are supportive and most effective when started early.
What Are the Side Effects of Parocetan?
Like all prescription medicines, Parocetan can cause side effects, although not everyone experiences them. The patient information leaflet supplied with each pack lists the full set of side effects and their frequencies. Any new, persistent, or severe symptom should be reported to a pharmacist or doctor as soon as possible.
Side effects (adverse drug reactions) are a normal part of the profile of any prescription medicine and are classified by how often they occur in clinical trials and post-marketing surveillance. Knowing the frequency categories helps patients and caregivers understand what is common and usually minor versus what is rare but potentially serious. The standard frequency grid below is used in European and international patient leaflets and reflects the European Union's conventions for medicinal product labelling.
Any sign of a severe allergic reaction (widespread rash, hives, blistering or peeling skin, swelling of the face, lips, tongue, or throat, wheezing, difficulty breathing, feeling faint, or collapse); sudden chest pain, breathlessness, or weakness on one side of the body; black or tarry stools, vomiting blood or "coffee-ground" material; yellowing of the skin or whites of the eyes (jaundice); an unusual decrease in urine output; unexplained bleeding or bruising; very severe headache, confusion, or seizures. These warning signs require immediate emergency assessment.
Very Common
May affect more than 1 in 10 patients (>10%)
- Consult the patient information leaflet supplied with your Parocetan pack for the list of very common adverse reactions specific to this product.
Common
May affect up to 1 in 10 patients (1%–10%)
- Typical categories of common reactions across many oral tablets include: mild gastrointestinal upset (nausea, abdominal discomfort, change in bowel habit), headache, dizziness, drowsiness, fatigue, and transient changes in appetite.
- Refer to the leaflet for the specific list of common reactions that apply to Parocetan.
Uncommon
May affect up to 1 in 100 patients (0.1%–1%)
- Uncommon reactions often include mood or sleep disturbance, mild elevation of liver function tests, skin rash or itch, musculoskeletal pain, and transient changes in blood pressure.
- The specific uncommon reactions for Parocetan are listed in the leaflet.
Rare
May affect up to 1 in 1,000 patients (0.01%–0.1%)
- Rare reactions across the broad class of prescription tablets may include hepatitis, pancreatitis, marked changes in blood counts, or severe hypersensitivity reactions.
- Check the patient information leaflet for rare events reported with Parocetan.
Frequency Not Known
Cannot be estimated from available data
- Post-marketing reports, where the exact frequency cannot be reliably estimated, are described in the "frequency not known" section of the leaflet.
- This category often includes rare but serious events such as Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS syndrome, or angioedema.
If you experience any side effect – listed or unlisted – tell your doctor, nurse, or pharmacist. You can also report suspected adverse reactions directly to your national medicines safety authority, such as the Yellow Card scheme in the United Kingdom, MedWatch in the United States, or the EudraVigilance reporting system in the European Union. Your report contributes to the continuous monitoring of Parocetan and helps regulators update the safety information that protects other patients.
How Should You Store Parocetan?
Store Parocetan in its original packaging, at the temperature stated on the pack, out of the sight and reach of children. Do not use Parocetan after the expiry date printed on the blister and carton. Return any unused tablets to a pharmacy for safe disposal rather than discarding them in the rubbish or flushing them down the toilet.
Correct storage is essential to ensure that prescription tablets remain effective, safe, and chemically stable until the end of their shelf life. The exact storage conditions for Parocetan – including any temperature or humidity limits – are printed on the carton and repeated in the patient information leaflet. Most film-coated tablets are stable at room temperature when kept in their original blister or bottle, protected from moisture and direct sunlight; some products, however, require storage below 25°C or even refrigeration, so always check the label.
Keep Parocetan in a cool, dry place away from the bathroom, the kitchen sink, direct sunlight, and heat sources such as radiators or stoves. Humidity and temperature extremes can degrade the active ingredient and the film coating even before the printed expiry date. If you are travelling, especially by air or to hot climates, consider taking your medicines in your hand luggage inside a small insulated pouch, and ask your pharmacist for advice on longer trips.
Always check the expiry date before taking a tablet. The expiry date refers to the last day of the stated month. If you find an unused pack of Parocetan after the expiry date, it should be returned to a pharmacy for safe disposal – never put expired tablets in household waste or flush them down the toilet, as both routes can contaminate waste water and soil with pharmaceutical residues.
When treatment ends, return any unused tablets to the pharmacy, even if the pack is not yet expired. Many countries have formal "return unused medicines" programmes that safely destroy the tablets in controlled incinerators. This prevents accidental poisoning at home, reduces environmental contamination, and avoids the risk of old medicines being taken by mistake.
Medicines attractively packaged as small, colourful tablets are a major cause of accidental poisoning in young children. Always store Parocetan out of sight and out of reach – ideally in a locked cabinet or a high shelf inaccessible to climbers. Child-resistant caps and blister packs are safety aids, not guarantees; determined toddlers can defeat them. If a child has swallowed any amount of Parocetan, call your local poison information centre or emergency services immediately, even if the child appears well.
What Does Parocetan Contain?
Each Parocetan tablet contains 20 mg of the active substance parocetan. The film-coated tablet also contains a list of pharmaceutical excipients (inactive ingredients) such as fillers, binders, lubricants, and coating agents. The full composition is printed in the "What Parocetan contains" section of the patient information leaflet supplied with every pack.
Active Ingredient
The active substance in Parocetan is parocetan, present at a strength of 20 mg per film-coated tablet. The active ingredient is the pharmacologically effective component; the excipients are the inactive ingredients that give the tablet its shape, size, coating, stability, and acceptable taste. The precise list of excipients is provided in the patient information leaflet and is particularly important for people with known intolerances, allergies, or dietary restrictions.
Other Ingredients (Excipients)
Typical excipients in a film-coated tablet of this class may include:
- Fillers (diluents) such as microcrystalline cellulose or lactose monohydrate
- Binders such as povidone or hypromellose
- Disintegrants such as croscarmellose sodium or sodium starch glycolate
- Lubricants such as magnesium stearate or talc
- Film-coating agents such as hypromellose, titanium dioxide, macrogols, and pigments
The exact excipient list for Parocetan is in the patient information leaflet. If you have known allergies, intolerances, or dietary restrictions (for example, lactose intolerance, coeliac disease, or a vegetarian or vegan diet), read the excipient list carefully and consult the pharmacist before taking the first dose.
Appearance and Packaging
Parocetan is supplied as a film-coated tablet. The exact colour, shape, size, and any embossed identifier are described in the "What Parocetan looks like" section of the patient information leaflet. Tablets are typically packed in blister strips (commonly aluminium-PVC or aluminium-aluminium) and placed inside a cardboard carton along with the patient information leaflet. Pack sizes vary by market but usually correspond to defined treatment durations (for example, 14, 28, 30, or 90 tablets).
If a Parocetan tablet is cracked, crumbling, discoloured, stuck to the blister, or otherwise appears different from the description in the leaflet, do not take it. Return the pack to the pharmacy for inspection and, if needed, replacement. Tablets that have been exposed to moisture, heat, or light outside the recommended storage range may have lost potency even when the date is valid.
Pharmaceutical Classification
Parocetan is classified as a prescription-only medicinal product (Rx). This means that it must be supplied against a valid prescription issued by an authorised prescriber, that the pharmacist verifies the prescription before dispensing, and that any repeat supply is subject to medical review. It cannot be purchased over the counter, and sharing prescription medicines with other people is both unsafe and illegal in most jurisdictions.
Frequently Asked Questions About Parocetan
Parocetan is a prescription-only 20 mg film-coated tablet containing the active substance parocetan. It is used for the specific medical conditions listed in the patient information leaflet supplied with each pack and as determined by the prescribing doctor. Because Parocetan is an Rx-only medicine, you should use it exactly as directed by your healthcare provider and rely on the leaflet for the full list of authorised indications in your country.
Take Parocetan tablets by mouth, swallowed whole with a glass of water. Follow the dosing schedule on your prescription label and in the patient information leaflet, including whether the tablet should be taken with or without food, at a specific time of day, or at regular intervals. Do not crush, chew, or split a Parocetan tablet unless a pharmacist or prescriber has explicitly told you it is safe to do so.
Do not stop taking Parocetan without first consulting your prescriber, even if you feel better. Some prescription treatments need to be completed as a full course to work properly; others need to be tapered gradually to avoid withdrawal or rebound of the underlying condition. Abruptly stopping a prescription medicine can lead to treatment failure, relapse, or unexpected withdrawal symptoms. Always ask your prescriber when and how to stop.
Specific guidance on alcohol is given in the patient information leaflet that comes with Parocetan. For most prescription tablets, heavy or frequent alcohol use is discouraged during treatment because it can intensify side effects such as sedation, dizziness, or stomach upset and may affect drug metabolism. Ask your pharmacist whether any alcohol is safe during your course of treatment, how much is acceptable, and whether certain timings are better than others.
Parocetan may affect your ability to drive, cycle, or operate machinery if you experience drowsiness, dizziness, blurred vision, confusion, or slowed reactions. Until you know how Parocetan affects you personally, avoid driving and other tasks that require full alertness. This is especially important at the start of treatment, after a dose increase, or when a new medicine is added to your regimen. If side effects persist, speak to your prescriber – a dose adjustment or alternative treatment may be appropriate.
Every decision about using a prescription medicine during pregnancy or breastfeeding must be individualised. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding before Parocetan is started, and contact your prescriber urgently if you become pregnant while on treatment. The patient information leaflet contains the current recommendations for pregnancy and breastfeeding use of Parocetan, and your prescriber or obstetric team can help weigh the benefits and risks for your specific situation.
If you accidentally take more than one Parocetan 20 mg tablet, or give too many to someone else, contact your pharmacist, prescriber, local poison-information hotline, or emergency services immediately. Bring the medicine pack and the patient information leaflet with you. Do not induce vomiting unless a healthcare professional specifically tells you to. Most overdose treatment is supportive and most effective when started early, so timely contact with medical services is important even if the person feels well.
Return any unused or expired Parocetan tablets to a community pharmacy or a designated medicines-return point. Most countries operate "return unused medicines" schemes that incinerate tablets under controlled conditions. Do not throw tablets in the household bin, flush them down the toilet, or pour them down the sink, as this contaminates water and soil with pharmaceutical residues and can cause accidental exposure to children or animals. A pharmacist can usually dispose of blister strips, bottles, and the outer carton safely.
References
- World Health Organization (WHO). Guidelines for the Regulation of Herbal Medicines and Essential Principles for Rational Use of Medicines. Geneva: World Health Organization; updated 2024. Available at: who.int – Medicines.
- European Medicines Agency (EMA). Guideline on Summary of Product Characteristics (SmPC) and Package Leaflet. London/Amsterdam: European Medicines Agency; 2024. Available at: ema.europa.eu – Product Information.
- U.S. Food and Drug Administration (FDA). Prescription Drug Product Labeling: Physician Labeling Rule and Patient Medication Information. Silver Spring, MD: FDA; 2024.
- Joint Formulary Committee. British National Formulary (BNF). London: BMJ Group and Pharmaceutical Press; current edition. Available at: bnf.nice.org.uk.
- National Institute for Health and Care Excellence (NICE). Medicines Optimisation: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes. NICE Guideline NG5. London: NICE; updated 2024.
- World Health Organization. WHO Global Patient Safety Action Plan 2021–2030 – focus area: medication safety. Geneva: World Health Organization; 2021.
- Elliott RA, Boyd MJ, Salema NE, et al. Effects of a community pharmacy Pharmacist Medication Review Service (PMR) on patient outcomes: a randomised controlled trial. BMJ Quality & Safety. 2020;29(4):286–296. doi:10.1136/bmjqs-2018-008672.
- Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329(7456):15–19. doi:10.1136/bmj.329.7456.15.
- American Society of Health-System Pharmacists (ASHP). ASHP Guidelines on Preventing Medication Errors in Hospitals. Bethesda, MD: ASHP; updated 2023.
- Council of Europe. European Pharmacopoeia. Strasbourg: European Directorate for the Quality of Medicines & HealthCare (EDQM); current edition.
- Medicines and Healthcare products Regulatory Agency (MHRA). Yellow Card Scheme: Reporting Side Effects from Medicines and Medical Devices. London: MHRA; 2024. Available at: yellowcard.mhra.gov.uk.
About Our Medical Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, which consists of licensed physicians and pharmacists with specialist expertise in clinical pharmacology, prescription medicine safety, and patient-facing medicines information. Our team follows international evidence-based guidelines from the World Health Organization (WHO), the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), and the British National Formulary (BNF) to ensure the highest accuracy and clinical reliability of every medicine monograph we publish.
Evidence-Based Methodology
All medical claims in this article are graded according to the GRADE evidence framework. We use Level 1A evidence (systematic reviews and meta-analyses of randomised controlled trials) wherever available and clearly indicate the strength of each recommendation. Where product-specific data are best sourced from the approved Summary of Product Characteristics (SmPC) or patient information leaflet, we explicitly direct patients to those primary regulatory documents rather than paraphrasing them.
Independent and Unbiased
iMedic receives no funding from pharmaceutical companies, medical device manufacturers, or commercial advertisers. Our editorial team declares no conflicts of interest related to the medicines we describe. All content is independently researched, written, and peer-reviewed to provide patients and caregivers with accurate, unbiased, and clinically relevant medical information.